NCT05514327View on ClinicalTrials.gov

A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions
Diffuse Large B Cell LymphomaCAR-TRadiotherapyBridging Therapy
Interventions
RADIATION

ultra-fraction radiotherapy

the R/R DLBCL patients would receive ultra-fraction radiotherapy as bridging therapy before the CD19 CART cell infusion

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER